Follow the Pundits

Tag: Funanc1al Contrarian Picks

Illustration of a movie theater marquee reading “Paramount Comeback?” with popcorn, stock charts, and streaming icons (like a play button and Wi-Fi signal), symbolizing the battle between traditional media and digital disruption.

GAMCO Investors Is Full of Winners — Except Paramount (PARA): Why This One Dud Might Finally Shine

Is Paramount Global a value trap—or a future media giant in disguise? Streaming growth, big-name backers like GAMCO and Vanguard, and Apple buyout rumors make this drama worth watching. 🍿🎥

Read entire article

Tags: Funanc1al, Funanc1al Contrarian Picks, GAMCO, HollywoodStocks, HollywoodStudios, Investing, MarioGabelli, MediaStocks, PARA, Paramount, StockAnalysis, StockMarket, StocksToWatch, StreamingStocks, ValueInvesting, ViacomCBS, WallStreet, WarrenBuffett
Investor hiker climbing a brain-shaped Acadia National Park trail marked by biotech milestones, symbolizing ACADIA Pharmaceuticals’ growth potential.

ACADIA Pharmaceuticals: Biotech Powerhouse Baker Bros Still Believes. Should You Buy In?

Biotech heavyweight Baker Bros still owns over 25% of ACADIA Pharmaceuticals (ACAD), and the stock is heating up. With expanding revenue, a rich CNS pipeline, and smart money backing it, is this the comeback story investors have been waiting for?

Read entire article

Tags: ACAD, ACADIA Pharmaceuticals, Baker Bros, Biotech Investing, Biotech Stocks, Funanc1al, Funanc1al Contrarian Picks, Funanc1al for Investors, Funanc1al Investing, Funanc1alBiotech, Funanc1alEdge, Funanc1alFinance, Funanc1alFun, Funanc1alHumor, Funanc1alInsiders, Funanc1alInvesting, Funanc1alMentalHealth, Funanc1alPharma, Funanc1alStocks, Growth Investing, Hedge Funds Investing, High-Conviction Investing, insider holdings, Parkinson’s disease, pharma pipeline, Rett Syndrome
Cartoon lion in tuxedo holding a movie clapperboard labeled 'LION (NYSE)' on red carpet, symbolizing Lionsgate insider buying and Hollywood stock opportunity.

Lionsgate Studios: Insiders Are Buying. Should the Stock Get the Lion's Share of Your Portfolio?

🦁 Liberty 77 Capital, led by ex-Treasury Secretary Steven Mnuchin, bought over 8 million shares of Lionsgate Studios (NYSE: LION). Revenues are up, insiders are bullish, and the studio is freshly split from Starz. Is it showtime—or a risky sequel?

Read entire article

Tags: Funanc1al, Funanc1al Contrarian Picks, Funanc1al for Investors, Funanc1al Investing, Funanc1al Turnaround Plays, Funanc1alEdge, Funanc1alFinance, Funanc1alHumor, Funanc1alStocks, insider buying, Liberty 77, LION, Lionsgate, Movie Stocks, Small Cap Stocks, Steven Mnuchin, Studio Stocks, Value Investing
Infographic on Bausch Health (BHC) featuring John Paulson’s insider buy, stock chart, and pharma recovery symbols with a contrarian twist.

Bausch Health: Paulson Doubles Down, Stock Breaks Out, Recovery Accelerates

Bausch Health ($BHC) is back in the spotlight as legendary investor John Paulson adds millions more in shares, fueling a breakout rally. With Q2 earnings showing revenue growth, profit rebound, and debt repayment plans, could BHC be staging its long-awaited comeback?

Read entire article

Tags: BauschHealth, BHC, BHCStock, BiotechTurnarounds, CarlIcahn, CheapStocks, ContrarianPlay, DeepValue, DoubleDown, Funanc1al, Funanc1al Contrarian Picks, Funanc1al Contrarian Plays, Funanc1al Edge, Funanc1al for Investors, Funanc1al Insider Series, Funanc1al Investing, Funanc1al Turnaround Plays, Funanc1alEdge, Funanc1alFun, Funanc1alInsiderSeries, Funanc1alInvesting, Funanc1alStocks, HealthcareStocks, HedgeFundBuying, InsiderBuying, Investing, John Paulson, JohnPaulson, Paulson, PharmaStocks, SmartMoneyMoves, StockMarketHumor, StocksToWatch, StocksWithHistory, TurnaroundStocks